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Introduction {#sec1}
============

Microtubule nucleation in cells is spatially and temporally controlled to ensure proper cytoskeleton function. The major nucleator is the γ-tubulin ring complex (γTuRC) in which several γ-tubulin complex proteins (GCPs) arrange 14 γ-tubulins into a helical arrangement so that they can serve as a template for microtubule nucleation ([@bib33], [@bib63]). The structure of γTuRC is best understood in budding yeast where 7 smaller "Y-shaped" γTuSC complexes, each consisting of 2 γ-tubulins and one copy of GCP2 and GCP3, assemble into a conically shaped assembly upon recruitment to the spindle pole body by Spc110 ([@bib34]). A cryoelectron microscopy (cryo-EM) reconstruction of budding yeast γTuSC in complex with a Spc110 fragment at 8-Å resolution revealed gaps between every second γ-tubulin in γTuRC creating a mismatch with the microtubule structure ([@bib32]). Microtubule nucleation by budding yeast γTuRC in this "open" conformation could be improved 2--3-fold by artificially closing these gaps through chemical crosslinking, suggesting a possible mechanism for activation of nucleation by budding yeast γTuRC ([@bib32]).

In fission yeast, filamentous fungi, and metazoans, some GCP2s and GCP3s are replaced in the complex by additional GCP4, GCP5, and GCP6 proteins and in metazoans γTuRC is a stable complex whose assembly is independent of the recruitment to target structures, such as centrosomes ([@bib17], [@bib38], [@bib44], [@bib45], [@bib63]). The exact stoichiometry and subunit order of human γTuRC is not known. Several proteins have been implicated in activating γTuRC, among which are MZT1 and MZT2, also sometimes classified as core components of the metazoan complex ([@bib28], [@bib33], [@bib37], [@bib59]), the recruitment factors CDK5Rap2 (functional homolog of budding yeast Spc110) ([@bib13], [@bib39], [@bib43]) and NEDD1 ([@bib57]), or microtubule dynamics regulators, such as the microtubule polymerase chTOG (XMAP215) or the multifunctional, catastrophe-suppressing protein TPX2 ([@bib7], [@bib47], [@bib57], [@bib61]).

A clear understanding of the mechanisms by which the efficiency of microtubule nucleation by human γTuRC is regulated is however lacking. The kinetics of microtubule nucleation either in the absence or presence of purified γTuRC have typically been measured either by following the turbidity of suspensions of nucleating microtubules over time or by fluorescence microscopy imaging of microtubules at distinct times after mixing γTuRC with tubulin ([@bib45], [@bib64]). Both types of assays have disadvantages, as they cannot distinguish easily between γTuRC-mediated and spontaneous microtubule nucleation and between microtubule nucleation and effects produced by microtubule growth and/or dynamic instability.

To overcome these limitations, we developed a microscopy-based *in vitro* nucleation assay that allows the real-time observation of the nucleation of individual microtubules by single surface-immobilized human γTuRCs, and we studied the structure of the γTuRC complex by cryo-EM combined with crosslinking mass spectrometry (CLMS). We found that human γTuRC-mediated nucleation is stochastic, highly cooperative, and faces a significant kinetic barrier. γTuRC improved the nucleation efficiency compared with spontaneous microtubule nucleation, but templated nucleation was still less efficient than microtubule plus-end elongation. A 4-Å resolution structure of human γTuRC revealed several features that are distinctly different from the structure of budding yeast γTuRC; surprisingly, γTuRC harbors actin in its central core and the complex is markedly asymmetric only partially matching the geometry of the active form of yeast γTuRC. Our results provide an explanation for the observed kinetic barrier for nucleation by human γTuRC and suggest a possible stimulatory function of additional factors that would morph γTuRC into a fully activated form.

Results {#sec2}
=======

Purification of Biotinylated Human γTuRC {#sec2.1}
----------------------------------------

We generated a HeLa Kyoto cell line that expressed a biotin acceptor peptide (BAP) and monomeric blue fluorescence protein (mBFP)-tagged GCP2 from a randomly integrated gene. Tagged GCP2 became incorporated into the human γTuRC complex and was biotinylated without compromising γTuRC function as indicated by the correct localization of the fluorescent complex to centrosomes and normal cell growth. We purified ∼ 0.1 mg tagged γTuRC from 120 g of cells in a one-day procedure using anion exchange, biotin affinity, and size exclusion chromatography ([STAR Methods](#sec4){ref-type="sec"}) ([Figures 1](#fig1){ref-type="fig"}A, 1B, and [S1](#mmc1){ref-type="supplementary-material"}).Figure 1Purification and Characterization of γTuRC-mBFP-BAP(A) Overview of purification steps.(B) Coomassie-stained SDS-PAGE of purified γTuRC. Protein bands corresponding to γTuRC subunits as identified by mass spectrometry are labeled.(C) Western blots of purified γTuRC using antibodies against γ-tubulin, GCP2, GCP4, actin, and mBFP. Biotinylation of the BAP was assessed by immunoblotting using horse radish peroxidase (HRP)-coupled streptavidin.(D) Negative-stain electron microscopy of purified γTuRC showing the expected 25-nm diameter ring structures. Two examples (white arrows) are shown as insets at higher magnification.(E) Schematic of TIRFM-based real-time γTuRC nucleation assay. Biotinylated fluorescent γTuRC is immobilized on a biotin-PEG-functionalized glass surface via NeutrAvidin. αβ-tubulin is added to initiate microtubule nucleation by immobilized γTuRC.(F) Representative TIRFM images showing the mBFP channel to visualize γTuRC on the surface (left panel) and showing the CF640R-tubulin channel to visualize nucleated microtubules (right panel) at t = 20 min after start of microtubule nucleation by a temperature jump to 33°C. 373 pM γTuRC was used for immobilization and the final CF640R-tubulin concentration was 15 μM. A representative control at 15 μM CF640R-tubulin without γTuRC is also shown. Intensities in the images are directly comparable.(G) Bar graph of the average microtubule number nucleated by surface-immobilized γTuRC (373 pM used for immobilization) within 15 min in presence of 15 μM CF640R-tubulin (n = 3). Error bars are SD. Scale bars as indicated. t = 0 is 2 min after placing the sample at 33°C. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}A.

Using mass spectroscopy, we identified all human γTuRC core subunits (γ-tubulin, GCP2-6), as well as MZT1, MZT2, and actin, which were co-purified in previous γTuRC purifications ([Figure S1](#mmc1){ref-type="supplementary-material"}C; [Data S1](#mmc10){ref-type="supplementary-material"}) ([@bib13], [@bib28], [@bib45], [@bib59], [@bib61]). Additionally, we verified most subunits also by western blot using specific antibodies ([Figure 1](#fig1){ref-type="fig"}C; see also [Figure S1](#mmc1){ref-type="supplementary-material"}B), indicating that the human γTuRC complex was successfully purified using our biotin affinity purification strategy. Purified γTuRC appeared as the typical characteristic "rings" with ∼25-nm diameter in negative-stain electron microscopy images ([Figure 1](#fig1){ref-type="fig"}D) ([@bib71]), confirming the presence of properly assembled complexes.

γTuRC Nucleates Single Microtubules and Caps Their Minus Ends {#sec2.2}
-------------------------------------------------------------

Next, we set up a microscopy-based real-time γTuRC-mediated microtubule nucleation assay ([Figure 1](#fig1){ref-type="fig"}E). We used NeutrAvidin to immobilize purified biotinylated γTuRC on a biotin-polyethylene glycol (PEG)-functionalized glass surface. Specific immobilization of biotinylated and mBFP-tagged γTuRC could be verified by measuring the mBFP fluorescence on NeutrAvidin surfaces and on surfaces lacking NeutrAvidin using total internal reflection fluorescence (TIRF) microscopy ([Figures 1](#fig1){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}A). In the presence of CF640R-labeled tubulin, microtubules nucleated from the γTuRC-coated surface, whereas hardly any microtubules nucleated in the absence of γTuRC under these conditions ([Figures 1](#fig1){ref-type="fig"}F and 1G).

Only one end of γTuRC-nucleated microtubules grew, whereas the other was tethered to the surface likely via γTuRC ([Figures 2](#fig2){ref-type="fig"}A, top rows, and 2B, left; [Video S1](#mmc2){ref-type="supplementary-material"}). In contrast, when microtubules elongated from surface-immobilized, stabilized microtubule "seeds" in control experiments, both microtubule ends grew ([Figures 2](#fig2){ref-type="fig"}A, bottom row, and 2B, right) with the faster plus-end growth speed of 26.8 ± 0.4 nm/s essentially equating the growth speed of γTuRC-nucleated microtubules of 26.3 ± 0.4 nm/s (errors are SEM) ([Figure 2](#fig2){ref-type="fig"}C, top). This observation demonstrates that γTuRC-nucleated microtubules grow exclusively at their plus end. Minus ends grew from "seeds" with a speed of 7.0 ± 0.2 nm/s, whereas surface-anchored minus ends of γTuRC-nucleated microtubules did not grow ([Figure 2](#fig2){ref-type="fig"}C, bottom). mGFP-labeled growing microtubule end marker EB3 decorated only the growing plus ends of γTuRC-nucleated microtubules ([Figures 2](#fig2){ref-type="fig"}D and 2E; [Video S2](#mmc3){ref-type="supplementary-material"}), similar to the situation in the cell ([@bib4]). In rare cases, γTuRC-nucleated microtubules first grew out of the TIRF field and later, remaining γTuRC-anchored, aligned with the surface only growing with one end ([Figures S2](#mmc1){ref-type="supplementary-material"}Bi and S2Bii). These data clearly demonstrate that, at our experimental conditions, plus ends of γTuRC-nucleated microtubules are dynamic and minus ends are capped by γTuRC. The occasional microtubule that nucleated in solution and then landed on the glass surface was easily distinguished from γTuRC-nucleated microtubules, as it became suddenly visible as an already elongated microtubule, displaying two dynamic microtubule ends and often also diffusing along the surface ([Figures S2](#mmc1){ref-type="supplementary-material"}Biii and S2Biv).Figure 2γTuRC Nucleates and Caps Microtubules at Their Minus End(A--C) Comparison between γTuRC microtubule nucleation assay and microtubule seed assay. Both assays were performed in the presence of 15 μM CF640R-tubulin. For γTuRC microtubule nucleation assay 373 pM γTuRC were used for immobilization. (A) Representative time series of individual microtubules (2 top rows of panels) nucleated on a γTuRC surface showing a static (purple arrow) and a fast-growing microtubule end. A control without γTuRC (bottom row) shows a microtubule growing from a stabilized microtubule "seed," displaying two growing microtubule ends with the minus end (purple arrow) growing more slowly than the plus end. (B) Representative TIRFM kymographs of microtubules nucleated by surface-immobilized γTuRC. For comparison a kymograph of a microtubule grown from a microtubule seed at the same tubulin concentration is shown. (C) Box-and-whiskers plots of microtubule plus-end (top) and minus-end (bottom) growth speeds for γTuRC nucleation assays and microtubule seed assays.(D and E) mGFP-EB3 tracks the growing plus end of γTuRC nucleated microtubules. Assays were performed in the presence of 12.5 μM CF640R-tubulin and 200 nM mGFP-EB3 using 373 pM γTuRC for immobilization. Data were pooled from two independent experiments. Number of microtubule growth speeds measured per conditions: γTuRC nucleation assay, plus-end growth: n = 86, minus-end growth: n = 71; microtubule seed assay, plus-end growth: n = 110, minus-end growth: n = 123. For the box-and-whiskers plots, boxes range from 25^th^ to 75^th^ percentile, the whiskers span from 10^th^ to 90^th^ percentile, and the horizontal line marks the mean value. (D) Representative time series of merged TIRFM images of two individual microtubules (magenta) nucleated from a γTuRC surface. mGFP-EB3 (green, white arrow) tracks the growing microtubule plus end, while the microtubule minus end is static. (E) Corresponding TIRFM kymographs.(F and G) Microtubules are nucleated by single γTuRC molecules. Assays were performed in the presence of 20 μM CF640R-tubulin using 27 pM γTuRC for immobilization. (F) Representative time series of merged TIRFM images showing individual microtubules (magenta) nucleated from single immobilized γTuRC molecules (cyan, white arrow). (G) Corresponding TIRFM kymographs. All experiments were performed at 33°C. Scale bars as indicated. t = 0 is 2 min after placing the sample at 33°C. See also [Figure S2](#mmc1){ref-type="supplementary-material"}B; [Video S1. γTuRC Nucleated Microtubules Are Capped at Their Minus Ends, Related to Figure 2A](#mmc2){ref-type="supplementary-material"}, [Video S2. mGFP-EB3 Tracks the Growing Microtubule Plus End of γTuRC Nucleated Microtubules, Related to Figure 2D](#mmc3){ref-type="supplementary-material"}, [Video S3. Microtubules Originate from Single Immobilized γTuRC Molecules, Related to Figure 2F](#mmc4){ref-type="supplementary-material"}.

Video S1. γTuRC Nucleated Microtubules Are Capped at Their Minus Ends, Related to Figure 2ATwo microtubules nucleated from a γTuRC surface (373 pM γTuRC used for immobilization) in the presence of 15 μM CF640R-tubulin. The static end is marked with a purple arrow. Time is in seconds. Scale bar, 5 μm.

Video S2. mGFP-EB3 Tracks the Growing Microtubule Plus End of γTuRC Nucleated Microtubules, Related to Figure 2DTwo microtubules nucleated from a γTuRC surface (373 pM γTuRC used for immobilization) in the presence of 12.5 μM CF640R-tubulin (magenta) and 200 nM mGFP-EB3 (green). mGFP-EB3 tracks the growing microtubule plus end, whereas the microtubule minus end is static. Time is in seconds. Scale bar, 5 μm.

Imaging the mBFP fluorescence of single immobilized γTuRC complexes at a reduced γTuRC density revealed that all surface-nucleated microtubules originated from a mBFP-labeled γTuRC ([Figures 2](#fig2){ref-type="fig"}F and 2G; [Video S3](#mmc4){ref-type="supplementary-material"}). Taken together, these data demonstrate that immobilized γTuRC stimulates microtubule nucleation, generating microtubules with a capped minus and a dynamic plus end. We did not observe microtubule detachment from immobilized γTuRC, indicating that γTuRC is stably bound to its nucleated microtubule within the entire duration of our experiments (20 min).

Video S3. Microtubules Originate from Single Immobilized γTuRC Molecules, Related to Figure 2FCF640R-labeled microtubules (magenta) nucleating from single mBFP-labeled γTuRC molecules (cyan, 27 pM γTuRC used for immobilization). Tubulin concentration was 20 μM. Time is in seconds. Scale bar, 2 μm.

γTuRC-Mediated Microtubule Nucleation Is Stochastic, Cooperative, and Not Very Efficient {#sec2.3}
----------------------------------------------------------------------------------------

Next, we quantified the number of γTuRC-nucleated microtubules per field of view, excluding the small fraction of microtubules nucleated in solution. Counting the γTuRC-nucleated microtubules, showed a linear increase of their number with time ([Figures 3](#fig3){ref-type="fig"}A and 3Bi; [Video S4](#mmc5){ref-type="supplementary-material"}). This demonstrates that γTuRC-mediated nucleation is a stochastic process with constant nucleation probability. Increasing the γTuRC density on the surface while keeping the tubulin concentration constant at 15 μM, demonstrated that the overall nucleation rate (increase of microtubule number per time and per surface area) increased with the γTuRC concentration used for γTuRC surface immobilization ([Figures 3](#fig3){ref-type="fig"}A and 3Bii; [Video S4](#mmc5){ref-type="supplementary-material"}) and with the measured mBFP intensity at the surface, i.e., the γTuRC density ([Figure 3](#fig3){ref-type="fig"}Biv). The microtubule growth speed was unaffected by the γTuRC density ([Figure 3](#fig3){ref-type="fig"}Biii), in agreement with the tubulin concentration essentially remaining unchanged in these experiments. We conclude that γTuRC stimulates nucleation in a dose-dependent manner.Figure 3The Microtubule Nucleation Efficiency of γTuRC Depends on γTuRC Surface Density and Tubulin Concentration(A and B) Microtubule nucleation at 33°C in the presence of 15 μM CF640R-tubulin at varying γTuRC concentrations used for immobilization (23, 47, 93, 187, 249, and 373 pM). (A) Representative time series of TIRFM images at the indicated γTuRC concentrations (top panel). For comparison, spontaneous microtubule nucleation in the absence of γTuRC at the same tubulin concentration is shown (bottom panel). (B) Plots showing (i) a linear increase in microtubule number over time, (ii) the mean γTuRC surface density (mBFP fluorescence in the field of view), (iii) the mean microtubule plus-end growth speed, and (iv) the mean microtubule nucleation rate (bottom right) at different γTuRC concentrations. Number of microtubule growth speeds measured per conditions: 23 pM, n = 27; 47 pM, n = 64; 93 pM, n = 96; 187 pM, n = 191; 249 pM, n = 160; 373 pM, n = 302.(C and D) Microtubule nucleation in presence of 373 pM γTuRC used for immobilization at varying CF640R-tubulin concentrations (7.5, 10, 12.5, 15, 18, and 20 μM). (C) Representative time series of TIRFM images of microtubule nucleation in the presence of the indicated CF640R-tubulin concentrations (top panel). For comparison, spontaneous microtubule nucleation in the absence of γTuRC is shown for the highest tested tubulin concentration (20 μM) (bottom panel). Spontaneous microtubule nucleation was always much less than γTuRC-mediated nucleation comparing the same tubulin concentrations (not shown). (D) Plots showing (i) the linear increase in microtubule number over time, (ii) the mean γTuRC surface density (mBFP fluorescence in the field of view), (iii) the mean microtubule plus-end growth speed, and (iv) the mean microtubule nucleation rate at different tubulin concentrations. Arrows mark the critical tubulin concentration for microtubule elongation (gray) defined as the intercept of the fit in [Figure 3](#fig3){ref-type="fig"}Diii with the x axis and the minimal concentration required for γTuRC-mediated nucleation (purple) and for spontaneous nucleation in the absence of γTuRC (green) both defined empirically as the tubulin concentration at which on average 1 or more microtubules become visible within 20 min in the field of view (164 × 164 μm). Number of microtubule growth speeds measured per conditions: 7.5 μM, n = 9; 10 μM, n = 51; 12.5 μM, n = 210; 15 μM, n = 190; 18 μM, n = 237; 20 μM, n = 244. Data for plots were pooled from at least three independent experiments. The plot of the nucleation rate against tubulin concentration (see [Figure 3](#fig3){ref-type="fig"}Div) was fit using a power law function. All other lines represent a linear regression. Nucleation rates (r~nuc~) were taken from the slope of the linear regression of the increase of microtubule number over time (see [Figures 3](#fig3){ref-type="fig"}Bi and 3Di). All experiments were performed at 33°C. All error bars are SEM. For symbols without visible error bars, error bars are smaller than the symbol size. Field of view was always 164 × 164 μm. AU, arbitrary units. Fluorescence intensities are directly comparable. Scale bars as indicated. t = 0 is 2 min after placing the sample at 33°C. See also [Figure S2](#mmc1){ref-type="supplementary-material"}C; [Videos S4](#mmc5){ref-type="supplementary-material"} and [S5](#mmc6){ref-type="supplementary-material"}.

Video S4. Microtubule Nucleation Efficiency Depends on γTuRC Surface Density, Related to Figure 3AMicrotubule nucleation and growth of CF640R-labeled microtubules from a surface containing an increasing density of immobilized γTuRC (left to right, 47, 187, and 373 pM γTuRC used for immobilization). Tubulin concentration was 15 μM. Time is in minutes. Scale bar, 20 μm.

Next, we changed the tubulin concentration keeping the γTuRC density constant ([Figures 3](#fig3){ref-type="fig"}C and 3Dii; [Video S5](#mmc6){ref-type="supplementary-material"}). While the microtubule growth speed increased linearly with tubulin concentration, as expected ([Figure 3](#fig3){ref-type="fig"}Diii), the nucleation rate increased very non-linearly with tubulin concentration ([Figures 3](#fig3){ref-type="fig"}C, 3Di, and 3Div), in agreement with an early study using *Xenopus* γTuRC ([@bib71]). A fit to the γTuRC-mediated dependence of the nucleation rate on the tubulin concentration using a power law (line in [Figure 3](#fig3){ref-type="fig"}Div) yielded an exponent of 6.7, demonstrating that γTuRC-mediated nucleation is a highly cooperative process, similar to spontaneous nucleation in solution ([@bib16], [@bib36], [@bib64]); however, γTuRC-mediated nucleation is clearly more efficient than spontaneous nucleation at all tubulin concentrations ([Figure S2](#mmc1){ref-type="supplementary-material"}C). The fit to the power law can also be used to provide an estimate for the minimal size of a templated tubulin assembly on γTuRC that allows stable microtubule outgrowth, which is in the range of one to two times the value of the exponent ([@bib36], [@bib64]). The minimal tubulin concentration required for detectable γTuRC-mediated nucleation was 7.5 μM and hence significantly lower than the ∼15 μM for spontaneous nucleation in solution in the absence of γTuRC ([Figure 3](#fig3){ref-type="fig"}Div: microtubule elongation \[gray arrow\], γTuRC-mediated nucleation \[purple arrow\], and spontaneous nucleation \[green arrow\]) ([Figure S2](#mmc1){ref-type="supplementary-material"}C) ([@bib10], [@bib20], [@bib51]). However, γTuRC-mediated nucleation required a tubulin concentration still higher than the 2 μM tubulin threshold above which pre-existing microtubule plus ends elongate ([Figure 3](#fig3){ref-type="fig"}Diii) ([@bib64], [@bib66]). This indicates that templating a new microtubule from γTuRC is easier than forming a new microtubule in solution, but it is clearly less efficient compared with elongating an existing growing microtubule end.

Video S5. γTuRC Microtubule Nucleation Efficiency Depends on Tubulin Concentration, Related to Figure 3CMicrotubule nucleation and growth of CF640R-labeled microtubules from a surface containing immobilized γTuRC (373 pM used for immobilization) in the presence of increasing concentration of tubulin (from left to right, 7.5, 12.5, and 20 μM). Time is in minutes. Scale bar, 20 μm.

Comparing the number of γTuRC complexes on the surface as measured by the number of mBFP dots with the number of nucleation events at 20 μM tubulin revealed that only ∼0.5% of complexes nucleated a microtubule within 9 min at our conditions. Therefore, γTuRC-mediated microtubule nucleation appears to be rather inefficient, suggesting that most likely additional factors are required for activating the complex or for promoting nucleation by stabilizing a freshly nucleated nascent microtubule. Therefore, using our nucleation assay we tested the effects on human γTuRC-mediated microtubule nucleation elicited by three proteins that are known to affect microtubule dynamics by preferentially binding to microtubule ends and that have also been reported to affect nucleation in different ways.

chTOG and TPX2 Stimulate γTuRC-Mediated Microtubule Nucleation {#sec2.4}
--------------------------------------------------------------

The microtubule polymerase chTOG/XMAP215 ([@bib11], [@bib21]) is known to mildly stimulate spontaneous microtubule nucleation *in vitro* ([@bib22], [@bib50]). In the presence of human chTOG, nucleation from surface-immobilized γTuRC is strongly promoted ([Figures 4](#fig4){ref-type="fig"}A--4C; [Video S6](#mmc7){ref-type="supplementary-material"}), in agreement with previous reports using the budding yeast and *Xenopus* orthologs of these proteins ([@bib26], [@bib61]). We find here that chTOG stimulates microtubule nucleation by human γTuRC by a factor of up to 21-fold ([Figure 4](#fig4){ref-type="fig"}C), with the stimulatory effect saturating in a physiological concentration range (100 nM in *Xenopus* egg extract; [@bib35], [@bib49], [@bib68]). Saturation of the acceleration of microtubule plus-end growth by chTOG occurs at a similar concentration ([Figures 4](#fig4){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}), suggesting that both chTOG effects are related and saturate when plus-end-binding sites at microtubule ends are fully occupied by chTOG. Thus, acceleration of outgrowth of a nascent microtubule forming on γTuRC may be one mechanism to increase overall nucleation efficiency ([@bib51]).Figure 4Microtubule Associated Proteins Can Increase the Microtubule Nucleation Efficiency of γTuRC(A--D) γTuRC-mediated microtubule nucleation in the presence of different chTOG-mGFP concentrations (6, 13, 25, 50, and 100 nM). Assays were performed in the presence of chTOG-mGFP and 10 μM CF640R-tubulin using 373 pM γTuRC for immobilization. (A) Representative TIRFM images of γTuRC-mediated microtubule nucleation in the presence of different chTOG-mGFP concentrations, as indicated. Microtubules are magenta, chTOG-mGFP is green. Plots showing, (B) linearly increasing microtubule numbers over time, (C) the mean microtubule nucleation rate, and (D) the mean microtubule growth speed at different chTOG-mGFP concentrations. Number of microtubule growth speeds measured per conditions: 23 pM, n = 27; 47 pM, n = 64; 93 pM, n = 96; 187 pM, n = 191; 249 pM, n = 160; 373 pM, n = 302.(E--H) γTuRC-mediated microtubule nucleation in the presence of different mGFP-TPX2 concentrations (49, 98, 195, and 390 nM). Assays were performed in the presence of mGFP-TPX2 and 10 μM CF640R-tubulin using 373 pM γTuRC for immobilization. (E) Representative TIRFM images of γTuRC-mediated microtubule nucleation in the presence of mGFP-TPX2 concentrations (green), as indicated. Plots showing, (F) linearly increasing microtubule numbers over time, (G) the mean microtubule nucleation rate, and (H) the mean microtubule growth speed at different mGFP-TPX2 concentrations. Number of microtubule growth speeds measured per conditions: 0 nM, n = 15; 49 nM, n = 50; 98 nM, n = 77; 195 nM, n = 143; 390 nM, n = 105.(I--L) γTuRC-mediated microtubule nucleation in the presence of different mGFP-EB3 concentrations (50, 100, 200, and 400 nM). Assays were performed in the presence of mGFP-EB3 and 12.5 μM CF640R-tubulin using 373 pM γTuRC for immobilization. (I) Representative merged TIRFM images of γTuRC-mediated microtubule nucleation in the presence of different mGFP-EB3 concentrations (green), as indicated. Plots showing, (J) linearly increasing microtubule numbers over time, (K) the mean microtubule nucleation rate, and (L) the mean microtubule growth speed at different mGFP-EB3 concentrations. Number of microtubule growth speeds measured per conditions: 0 nM, n = 210; 50 nM, n = 132; 100 nM, n = 230; 200 nM, n = 191; 400 nM, n = 290. As controls, representative TIRFM images in either the absence of microtubule associated proteins or absence of γTuRC are shown for the highest tested concentration of the various microtubule-associated proteins. Lines represent the linear regression. Nucleation rates (r~nuc~) were taken from the slope of the linear regression of the increase of microtubule number over time (see [Figures 4](#fig4){ref-type="fig"}B, 4F, and 4J). All experiments were performed at 33°C. All error bars are SEM. For symbols without visible error bars, error bars are smaller than the symbol size. Field of view was always 164 × 164 μm. AU, arbitrary units. Fluorescence intensities are directly comparable. Scale bars as indicated. t = 0 is 2 min after placing the sample at 33°C. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}; [Videos S6](#mmc7){ref-type="supplementary-material"} and [S7](#mmc8){ref-type="supplementary-material"}.

Video S6. chTOG-mGFP Synergistically Increases γTuRC Nucleation Efficiency, Related to Figure 4AMicrotubule nucleation and growth of CF640R-labeled microtubules in the presence of γTuRC (left), γTuRC and chTOG-mGFP (middle), or mGFP-chTOG (right). Tubulin concentration was 10 μM (magenta), chTOG-mGFP concentration was 100 nM (green), and 373 pM of γTuRC was used for immobilization. Time is in minutes. Scale bar, 20 μm.

TPX2, a protein involved in chromatin-dependent microtubule nucleation, can also stimulate nucleation *in vitro* ([@bib7], [@bib50], [@bib55]). We tested here to which extent TPX2 could stimulate microtubule nucleation from immobilized γTuRC. We measured microtubules nucleating from the γTuRC surface, excluding the only minor fraction of those microtubules that nucleate from local TPX2 accumulations possibly representing recently reported TPX2 condensates forming at high TPX2 concentrations ([@bib31]) ([Figure S4](#mmc1){ref-type="supplementary-material"}). We observed that TPX2 stimulated γTuRC-mediated microtubule nucleation in a dose-dependent manner ([Figures 4](#fig4){ref-type="fig"}E--4G; [Video S7](#mmc8){ref-type="supplementary-material"}), however, only at rather high concentrations compared with physiological TPX2 concentrations (25--100 nM in *Xenopus* egg extract; [@bib23], [@bib62], [@bib68]). TPX2 had no strong effect on microtubule growth speed ([Figure 4](#fig4){ref-type="fig"}H), as reported previously ([@bib50], [@bib66]). Therefore, TPX2 likely promotes γTuRC-mediated nucleation *in vitro* by a different mechanism compared with chTOG, possibly by suppressing depolymerization of a nascent microtubule on γTuRC, through its catastrophe-suppressing activity ([@bib50], [@bib66]). In contrast to chTOG and TPX2, we did not observe any effect of the plus-end-tracking protein EB3 on γTuRC-mediated nucleation ([Figures 4](#fig4){ref-type="fig"}I--4L).

Video S7. mGFP-TPX2 Increases γTuRC Microtubule Nucleation Efficiency in a Dose-Dependent Manner, Related to Figure 4EMicrotubule nucleation and growth of CF640R-labeled microtubules in the presence of γTuRC (left), γTuRC and mGFP-TPX2 (middle), or mGFP-TPX2 (right). Tubulin concentration was 10 μM (magenta), mGFP-TPX2 concentration was 390 nM (green), and 373 pM of γTuRC was used for immobilization. Time is in minutes. Scale bar, 20 μm.

The Cryo-EM Structure and CLMS Analysis of Human γTuRC {#sec2.5}
------------------------------------------------------

To understand the molecular basis of microtubule nucleation, we determined the cryo-EM structure of γTuRC to a resolution of 4 Å (or 3.7 Å after cryo-EM density modification; [@bib60]; [Figure S5](#mmc1){ref-type="supplementary-material"}; also see [Table 1](#tbl1){ref-type="table"}). The complex is arranged in a left-handed spiral cone (reminiscent of a churros paper wrap), narrowing at one end, with a 300-Å largest diameter and a height of 200 Å ([Figure 5](#fig5){ref-type="fig"}A). The spiral is formed by 14 similar modules ("stalks"), which support 14 globular features decorating the largest face of the complex. Comparison with the crystal structure of the GCP4 subunit of γTuRC (PDB:[3RIP](pdb:3RIP){#intref0010}) ([@bib24]) allows the immediate identification of 14 different GCP protomers forming the spiral, which we number starting from the narrow bottom to the large-face top of the spiral. Notably, subunit 14 at the top of the spiral aligns with the lowermost subunit 1 ([Figure 5](#fig5){ref-type="fig"}B). Inter-GCP interactions closely resemble those observed at the GCP2-GCP3 interface visible in the yeast γTuSC complex structure ([@bib32]). While GCP subunits 1--8 in γTuRC engage in tight inter-protomer interactions that involve both the constricted side and the larger side of the cone, subunits 9--14 merely interact at the tip of the cone and appear more flexible as they depart radially from the core of the structure ([Figure 5](#fig5){ref-type="fig"}A). The globular densities decorating the wider side of the GCP cone was rigid-body fitted by 14 γ-tubulin protomers (PDB:[1Z5W](pdb:1Z5W){#intref0015}) ([@bib5]), resulting in a configuration akin to the γTuSC structure ([@bib32]) ([Figure 5](#fig5){ref-type="fig"}B).Table 1Data Collection and Refinement StatisticsγTuRC Cryo-EM Data Collection and Map RefinementMicroscopeTitan Krios TEM (Thermo Fisher)DetectorK2 summit (Gatan) in counting modeNominal magnification130,000Voltage (kV)300Electron exposure (e^−^/Å^2^)50Defocus range (μm)−1.0 to −3.5Pixel size (Å)1.08SymmetryC1Initial particle images (no.)1,100,000Final particle images (no.)522,496Sharpening B-factor−100FSC threshold0.143Map resolution (Å)4.0Map resolution range (Å)3.5 to 8.5Figure 5Cryo-EM Structure of Human γTuRC(A) Surface rendering of the cryo-EM structure viewed from the top and side. γTuRC is shaped like a cone with a base diameter of 300 and height of 200 Å.(B) γTuRC contains 14 stalk protomers that support 14 globular densities. Subunits in the lowermost position 1 and the uppermost position 14 are aligned. Docking of the human GCP4 crystal structure (PDB:[3RIP](pdb:3RIP){#intref0175}) into any of the spiral cone positions reveals that the 14 stalk densities correspond to GCP proteins (position 1 is shown here as an example). A low resolution version of the cryo-EM map is shown to focus on the overall shape of the complex.(C) The 14 globular densities instead correspond to γ-tubulin, as revealed by atomic docking of PDB:[1Z5V](pdb:1Z5V){#intref0180}, here shown docked into position 8 as an example. Nucleotide density (GTPγS in the crystal structure used) is shown in red.

Although the local resolution of the γ-tubulin subunits varies around the ring, nucleotide density can clearly be observed when the local resolution is high enough, for example, for γ-tubulin in position 11 ([Figure 5](#fig5){ref-type="fig"}C). Densities appear less defined for γ-tubulin in particular for positions 12, 13, and 14. Our resolution does not allow discrimination between guanosine triphosphate (GTP) and guanosine diphosphate (GDP) in the active site. GCP2-interacting γ-tubulin from the N-terminal bottom of the spiral appears engaged with the GCP3-interacting γ-tubulin pointing toward the C-terminal top of the spiral. Conversely, gaps of varying extents can be identified between γ-tubulins engaged by other GCP subunits ([Figure 5](#fig5){ref-type="fig"}B). Due to limits in resolution, we cannot comment on differences in the configuration of lateral loops in the γ-tubulin subunits around the γTuRC spiral.

As our mass spectrometry analysis of the purified human γTuRC identified all five paralogous GCP2, 3, 4, 5, and 6 subunits ([Figure S1](#mmc1){ref-type="supplementary-material"}C; [Data S1](#mmc10){ref-type="supplementary-material"}), we sought to identify each subunit in our 14-mer complex. We first generated homology models for human GCP2 and GCP3 based on human GCP4. Although the two homology models appeared similar to each other, GCP3 presented a characteristic helical extension in the C-terminal, γ-tubulin-interacting domain (also known as GRIP2 domain; [@bib24], [@bib25], [@bib44]) ([Figure 6](#fig6){ref-type="fig"}A). Given their structural homology, unique, structured sequence insertion and the well-documented ability to heterodimerize, we built a dimeric model for GCP2-GCP3 and docked it around all possible positions within the γTuRC cone. We found that GCP2-GCP3 best fits GCP positions 1--2, 3--4, 5--6, 7--8, and 13--14 with cross-correlation scores of 0.71, 0.69, 0.70, 0.70, and 0.72, respectively ([Figure 6](#fig6){ref-type="fig"}A). Conversely, positions 9-10 and 11-12 scored poorly (0.43 and 0.40, respectively), indicating that these protomers likely contain GCP4, 5, and 6.Figure 6GCP Subunit Assignment(A) GCP2 and GCP3 are known to form a stable heterodimer. Homology modeling indicates that GCP3 contains a unique α-helical extension, resulting in a distinctive feature that radially departs from the GCP spiral structure. This structural feature allows us to assign GCP2 and GCP3 around the γTuRC complex.(B) GCP4 can be assign by docking the human crystal structure into the cryo-EM map. This fitting exercise, even in the absence of any further real-space refinement, allows us to appreciate the match between amino acidic side chains from the X-ray model and the density features in the cryo-EM map. We therefore assign GCP4 to positions 9 and 11 in the map. Rigid-body docking of N-terminal (GRIP1) and MID-C-terminal domains (GRIP2) is required to optimize the fitting of each individual structure. Cryo-EM density obtained with Phenix's ResolveCryoEM is shown to highlight the fit of amino acidic side chains (central panel). The cryo-EM density sharpened with RELION post-processing is used elsewhere in the figure.(C) Top panel: circular representation of the CLMS results. Intra-subunit crosslinks are displayed as purple lines. Inter-subunit crosslinks are represented as green lines. Bottom panel: inter-molecular crosslinks between GCP subunits and actin help establish the subunit order around the γTuRC spiral.(D) GCP5 in position 10 contains a characteristic predicted helical extension in the MID domain.(E) Assigned to position 12, GCP6 contains the largest N-terminal extension (marked in black) and MID domain insertion (marked in red) among GCP protomers. Also see [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

To locate GCP4 in GCP positions 9, 10, 11, and 12 of the cryo-EM map, we employed cross-correlation searches in the constricted N-terminal region of the GCP spiral, where local resolution ranges from 3 to 3.5 Å. The human GCP4 N-terminal domain ("GRIP1" domain, [@bib24]) extracted from the crystal structure showed the highest correlation at GCP in positions 9 (0.62) and 11 (0.58), whereas positions 10 and 11 yielded lower scores (0.35 and 0.41, respectively). Amino acidic side chains of alpha helices in the crystallographic model match the density features in the N-terminal GCP4 cryo-EM map without the need of any real-space refinement ([Figure 6](#fig6){ref-type="fig"}B), providing us with confidence in the subunit assignment. The rest of the atomic structure was split in two additional domains (middle, "MID", and "C-terminal"), which were docked as independent rigid bodies to achieve the best-fitting results ([Figure 6](#fig6){ref-type="fig"}B).

To validate our homology-model-based assignment and locate GCP subunits 5 and 6, we performed CLMS analysis on the purified γTuRC complex. Structural interpretation of inter-protein crosslinks was focused on protein pairs that were crosslinked with three or more residue pairs. 16 protein pairs including all 5 displayed in [Figure 6](#fig6){ref-type="fig"}C passed this cutoff. A strong BS3 crosslink signal can be observed between GCP2 and GCP3, supporting the notion that the GCP2-GCP3 heterodimer is found in multiple copies around the ring. GCP4 cross linked with GCP5 and GCP6, while GCP6 also was observed to interact with GCP2 and GCP3 ([Figure 6](#fig6){ref-type="fig"}C; see also [Data S2](#mmc11){ref-type="supplementary-material"}). We generated a pseudo-atomic structure by docking homology models into the cryo-EM density and mapped the crosslinks on our structure. The best match between the atomic model and CLMS data contains GCP5 in GCP position 10, sandwiched between two GCP4 molecules in positions 9 and 11 and GCP6 in position 12, sandwiched between GCP4 in position 11, and GCP2 in position 13 ([Figure 6](#fig6){ref-type="fig"}C). Only this solution satisfies the physical constraints of the BS3 crosslinker (all inter-GCP crosslinks measure less than 25 Å for positions 9, 10, 11, 12, and 13). Coherent with this solution, GCP5 and GCP6 MID domains display density features that are absent in GCP4, as expected from their unique characteristic MID domain insertions. Furthermore, GCP6 contains a unique N-terminal appendix that can be recognized in GCP position 12 ([Figures 6](#fig6){ref-type="fig"}D and 6E). Two crosslinks between the GCP6 and GCP3 core domains visible in our pseudo-atomic models involve amino acids distant more than 30 Å apart. The most likely interpretation is that the GCP2-GCP3 heterodimer in positions 13-14 is highly flexible and could come in closer proximity to GCP6, when engaged in stabilizing interactions, as further addressed in the discussion section.

Peripherally Bound MZT2 and an Internal Actin Appear to Form Stabilizing Contacts {#sec2.6}
---------------------------------------------------------------------------------

Focusing next on the residual unoccupied density, we noted that specific N-terminal GCP interfaces (in positions 1-2, 3-4, 5-6, 7-8, and 13-14) contacted a discernible Λ-shaped α-helical feature, lining the outer perimeter of the constricted cone end ([Figure 7](#fig7){ref-type="fig"}A). This feature appears to seal off the GCP2-GCP3 interface, occupying a position that matches that of Spc110, required for stable γTuSC complex formation in yeast ([@bib32]) ([Figure 7](#fig7){ref-type="fig"}B). CLMS analysis assigns this feature to MZT2, as it crosslinks with GCP2 and GCP3 elements on the outer perimeter of the γTuRC N-terminal constriction. Importantly, 5 of the 6 GCP2-GCP3 residues, which crosslink with MZT2 and are visible in our pseudo-atomic model, are surface exposed and map less than 25 Å away from the Λ-shaped feature ([Figure 7](#fig7){ref-type="fig"}B). Conversely MZT1 crosslinks with C-terminal GCP2, N-terminal GCP3, and N-terminal GCP6. No obvious unoccupied features were detected in our cryo-EM map, indicating that MZT1 is only flexibly tethered to the core of the γTuRC assembly. On one end of the spiral, proximal to the γ-tubulin face, we could additionally observe some unassigned C-terminal density contacting the GCP3 Cterminus, which might function as a cap that blocks further GCP polymerization, helping to define subunit composition in the γTuRC complex ([Figure 7](#fig7){ref-type="fig"}A).Figure 7Analysis of the Unassigned Cryo-EM Density in the γTuRC Complex(A) Unoccupied density appears to seal off the interface of GCP2 and GCP3, lining the outer perimeter of the GCP spiral (marked with an orange circle). A 90° tilted view highlights unassigned density can be observed departing from the C-terminal end of GCP3 in position 14 (shown in red).(B) The feature on the outer perimeter of the GCP spiral occupies the same position observed for Scp110 in γTuSC. CLMS identifies this feature as MZT2, as this factor is crosslinked with residues clustered on the outer face of the GCP2-GCP3 interface across a region of diameter smaller than 60 Å.(C) Two orthogonal views corresponding to additional density found in the lumen of the γTuRC spiral. Part of this density can be assigned to actin (magenta), which was found to be co-purified in our preparation. Additional unassigned density shown in gray contains three recognizable alpha helical bundles.(D) The luminal density bridges γ-tubulin in position 2 and GCP3 in position 8. Also see [Figure S6](#mmc1){ref-type="supplementary-material"}.

Additional, prominent density could also be observed within the lumen of the γTuRC cone. Actin co-purifies with γTuRC ([Figures 1](#fig1){ref-type="fig"}C, [S1](#mmc1){ref-type="supplementary-material"}B, and S1C) ([@bib13], [@bib45]). Attempting to dock one actin protomer (PDB:[2HF3](pdb:2HF3){#intref0020} [@bib53]) into the luminal density resulted in an unambiguous fit (cross-correlation coefficient 0.74, against a 0.49 score for a 180° rotated solution) and revealed direct contacts between both γ-tubulin and GCP3 in GCP position 2 ([Figure 7](#fig7){ref-type="fig"}C). CLMS analysis confirmed these contacts, for example, a crosslink between GCP3 lysine 276 and actin lysine 113 maps 30 Å apart in our structure, compatible with the linker length in the BS3 crosslinking reagent ([Figure 6](#fig6){ref-type="fig"}C). Actin also interacts with one unassigned luminal feature, formed by a helical repeat module, which straddles across the central pore of the helical assembly, bridging between γ-tubulin in position 2 with GCP3 in position 8 ([Figure 7](#fig7){ref-type="fig"}D). In our CLMS experiment, GCP3 crosslinked with a GCP6 large N-terminal extension that is missing in our model. Thus, N-terminal GCP6 is a strong candidate for the unassigned luminal feature, coherent with a recently proposed model ([@bib40]) ([Figure 6](#fig6){ref-type="fig"}C). No obvious structural change can be detected at our resolution for the actin-engaged γ-tubulin.

In summary, actin and associated luminal factors, as well as MZT2 on the outer perimeter of the assembly appear engaged in stabilizing interactions that hold together the γTuRC spiral. We note that γTuRC protomers in positions 1--8 match the GCP2-GCP3 configuration in the active ("closed") configuration of yeast γTuSC ([@bib32]). Conversely, subunits in positions 9--14, which notably lack any stabilizing element within the lumen, display a configuration more akin to the inactive ("open") form of yeast γTuSC ([@bib32]). Coherently, subunits in positions 1--8 appear to match the geometry of a 13-subunit microtubule protofilament and could hence sustain nucleation, possibly starting from position 2 in the γTuRC, which presents the first sterically available docking site on γ-tubulin. The observation that γTuRC subunits in positions 9--14 markedly diverge from microtubule geometry could justify our observation that γTuRC enhanced microtubule nucleation is not very efficient ([Video S8](#mmc9){ref-type="supplementary-material"}).

Video S8. γTuRC Structure Explains Why Microtubule Nucleation Faces a Kinetic Barrier, Related to Figures 5 and 6Overall view of the γTuRC structure, followed by a comparison between the compact and loosely interacting halves of the GCP spiral. The tetramer of GCP2-GCP3 heterodimers (green) follows the geometry of a 13 protofilament microtubule. The GCPs in the asymmetric part (purple) however depart from the microtubule geometry.

Discussion {#sec3}
==========

Using TIRF microscopy, we imaged the nucleation of individual microtubules by surface-immobilized human γTuRC. Microtubules were stably capped by γTuRC, not displaying any minus-end dynamics. γTuRC increased the nucleation efficiency compared with microtubule nucleation in solution, but nucleation still had to overcome a significant kinetic barrier. Microtubule formation on the γTuRC template was mechanistically very different from microtubule plus-end elongation. Determining the structure of the human γTuRC complex, using a combination of cryo-EM and CLMS, revealed an asymmetric conformation with half of the complex in a compact configuration (closed) and half containing loosely interacting protomers (open). As observed for budding yeast γTuRC ([@bib32]), the rise of the helical arrangement of the γ-tubulins imposes a "three start helix" microtubule lattice structure with the seam being positioned between γ-tubulin 1 and 2. The human γTuRC structure is however distinctly different from the structure of budding yeast γTuRC ([@bib32]), particularly where the GCP4, 5, and 6 subunits are located that are absent in yeast γTuRC.

Microtubule nucleation in solution has been described as a highly cooperative process. Many tubulins need to come together to form a first minimal stable assembly ([@bib64]). Although γTuRC is thought to nucleate microtubules by providing a template that mimics the microtubule structure, also nucleation from this template faced a kinetic barrier and was highly cooperative. Our estimate of at least ∼7 tubulins needing to come together before stable microtubule outgrowth from the γTuRC complex can occur ([Figure 3](#fig3){ref-type="fig"}D) is at the lower end of the reported range of 6--15 tubulins for such a critical nucleus required for spontaneous nucleation in solution ([@bib19], [@bib36], [@bib64]), supporting the notion that the template facilitates nucleation.

However, microtubule outgrowth from the γTuRC template is considerably more difficult than elongation from a pre-existing growing microtubule plus end. Only a fraction of γTuRCs nucleated within 20 min in our assay. We did not observe any indication for a permanently inactive γTuRC population, because the probability of stochastic nucleation was constant over time. However, we cannot exclude that some purified and surface-immobilized complexes are permanently inactive.

Our γTuRC structure can explain the observed inefficient nucleation. Only half of the human γTuRC complex exists in a closed configuration with four GCP2-GCP3 heterodimers bound to 8 γ-tubulins being bridged together by stabilizing factors including one actin monomer in the lumen of the cone-shaped complex. Conversely, the other half of the complex where GCP4-GCP5 and GCP4-GCP6 subunits are located, together with one additional GCP2-GCP3 dimer at the very top of the helical arrangement of GCP dimers, lack bridging luminal elements and only loosely interact with one another. This open configuration causes a γ-tubulin arrangement that deviates from the microtubule geometry and that is expected for an active γTuRC state ([Video S8](#mmc9){ref-type="supplementary-material"}). This asymmetric structure indicates that the purified human γTuRC is not in a fully active conformation. Either microtubule assembly on the γTuRC surface may induce γTuRC closure and/or additional regulatory binding factors may induce a completely closed γTuRC geometry required for efficient nucleation, suggesting a mechanism for the regulation of γTuRC activity.

In favor of the scenario of microtubule assembly-induced γTuRC closure is our observation that proteins, which stabilize growing microtubule ends by different means and which were shown to stimulate microtubule nucleation *in vitro*, also stimulate γTuRC-mediated microtubule nucleation. The microtubule polymerase chTOG may do so by accelerating and thereby stabilizing nascent microtubule growth on γTuRC by its polymerase activity ([@bib11], [@bib50]), and TPX2 may do so by its catastrophe-suppressing activity ([@bib50], [@bib66]). chTOG and TPX2 were also reported to promote microtubule outgrowth from stabilized microtubule "seeds," suggesting similarities between outgrowth from such seeds and templating a microtubule by γTuRC ([@bib66]). Interestingly, both chTOG and TPX2 have also been reported to directly interact with γTuRC, which may increase the efficiency of their action ([@bib7], [@bib61]). However, we did not observe evidence of significant binding of these proteins to our passivated surfaces with specifically immobilized γTuRC. Moreover, TPX2 has been shown to interact additionally with the HAUS (Augmin) complex that promotes branched microtubule nucleation from pre-existing microtubules in mitotic or meiotic spindles during cell division ([@bib6]).

Our structure suggests a potential mechanism for the activation of human γTuRC by complex closure. In our structure, all GCP2-GCP3 interfaces in the closed part of the complex are sealed off by MZT2, an inter-protomer element, in a position reminiscent of yeast γTuSC specific Spc110. As for Spc110, we propose that MZT2 is likely required to stabilize the GCP2-GCP3 spiral formation at the constricted N-terminal dimerization core. At least 5 additional binding sites in the open part of the complex remain available at inter-protomer interfaces along the perimeter of the constricted spiral base, which could be engaged by additional nucleation-activation factors.

These elements in the γTuRC structure suggest an activation mechanism for human γTuRC that differs from the activation mechanism for budding yeast γTuRC. This difference is likely a consequence of different GCP subunit compositions of the two complexes. Yeast γTuRC consists of a helical arrangement of 7 identical γTuSCs (2 γ-tubulins and one GCP2 and 3 each) and displays gaps between every second γ-tubulin (within a γTuSC) that create a mismatch with the microtubule geometry ([@bib32]). Consequently, in addition to regulation at the level of complex assembly by recruitment factors to the spindle pole body, yeast γTuRC can be further activated by a structural change closing the gaps between the γ-tubulins, resulting in a γ-tubulin arrangement that matches the 13-mer protofilament geometry of the microtubule ([@bib32]). In contrast, the human γTuRC structure departs from the microtubule geometry where GCP4, 5, and 6 are located, resulting in an entire half of the complex being in an open conformation. It is tempting to speculate that other proteins that may line the outer perimeter of the open part of γTuRC (or its inner lumen) may induce a conformational change, closing the second half of the complex and thereby producing a completely closed conformation in which the γ-tubulin configuration closely matches the geometry of the microtubule lattice. Such reconfiguration may consequently reduce the kinetic barrier for templated microtubule nucleation.

Cryo-EM structures of the human and *Xenopus* γTuRC complex have recently been published ([@bib40], [@bib67]). Overall, these structures are similar to the structure reported here. However, some differences with the previously published structure of the human complex can be observed. An unidentified factor binds between subunits GCP4 and GCP6 in positions 11 and 12, respectively ([@bib67]), which is absent in our structure of the complex. This factor appears to stabilize the interaction between GCP4 and GCP6, which display a more compact interface than in our structure, possibly representing a partially activated complex.

Moreover, it is interesting to note that the γ-tubulin used in our docking experiment exists in a curved configuration ([@bib5]), different from that of tubulin dimers incorporated in a microtubule lattice ([@bib9]). Additional conformational changes may be required for γ-tubulin as a microtubule assembles on the γTuRC template ([@bib67]).

A major open question for the future will be to understand how the various proteins involved in controlling the efficiency of microtubule nucleation in cells control the conformation and activity of human γTuRC. Real-time *in vitro* nucleation assays in combination with structural investigations will be essential to shed light on the detailed mechanism of spatiotemporal γTuRC activation, probably by an open-to-closed transition.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**γ-tubulin, clone GTU-88Sigma-AldrichCat\#: T6557; RRID: [AB_477584](nif-antibody:AB_477584){#intref0025}mTagBFPEvrogenCat\#: AB233;\
RRID: [AB_2571743](nif-antibody:AB_2571743){#intref0030}polyclonal rabbit anti-GCP2 antibody (amino acids 1-155)this studycostum-made, Pettingillpolyclonal rabbit anti-GCP4 antibody (amino acids: 1-745)this studycostum-made Covalabmouse anti-HA, clone F-7Santa Cruz BiotechnologyCat\#: sc-7392; RRID: [AB_627809](nif-antibody:AB_627809){#intref0035}anti-rabbit WestVision Peroxidase Polymer antibodyVectorCat\#: WB-1000; RRID: [AB_2336860](nif-antibody:AB_2336860){#intref0040}goat anti-mouse immunoglobulins/HRPAgilentCat\#: P0447;\
RRID: [AB_2617137](nif-antibody:AB_2617137){#intref0045}goat anti-mouse (H+L) antibody, FITC conjugateSigma-AldrichCat\#: 12-506;\
RRID: [AB_390186](nif-antibody:AB_390186){#intref0050}rabbit anti-actin, beta polyclonal antibodyAbcamCat\# ab8227;\
RRID:[AB_2305186](nif-antibody:AB_2305186){#intref0055}**Bacterial and Virus Strains**Bacterial strain for molecular cloning:\
*Escherichia coli* DH5αEMBLStrain name: DH5α**Chemicals, Peptides, and Recombinant Proteins**γTuRC-GCP2-mBFP-AviTagThis studyCorresponding recombinant DNA: pTC069mGFP-EB3Previously used by [@bib52]N/AmGFP-TPX2Previously used by [@bib50]N/AchTOG-mGFPPreviously used by [@bib50]N/APig brain tubulinPurified according to [@bib12]N/ACatalaseSigma-AldrichCat\#: C40Glucose OxidaseServaCat\#: 22778.01Bovine Serum AlbuminSigma-AldrichCat\#: 05470κ-caseinSigma-AldrichCat\#: C0406NeutrAvidinLifeTechnologiesCat\#: A2666(3-Glycidyloxypropyl)trimethoxy-silaneSigma-AldrichCat\#: 440167Biotin-CONH-PEG-NH~2~ (3000 Da)Rapp Polymere GmbHCat\#: 133000-25-20HO-PEG-NH~2~ (3000 Da)Rapp Polymere GmbHCat\#: 103000-20Streptavidin-HRPThermo FisherCat\#: 21130BS3 (bis(sulfosuccinimidyl)suberate)Thermo FisherCat\#: 21586**Deposited Data**Human γTuRCThis studyEMD-10744Crosslinking mass spectrometry dataThis studyPRIDE-PXD018106**Experimental Models: Cell Lines**HeLa Kyoto cells for recombinant GCP2-mBFP-AviTag expressionCell services, Francis Crick InstituteCVCL_1922**Oligonucleotides**Primers for GCP2-mBFP-AviTag in pLVX-Puro: GGACTCAGATCT\
CGAATGAGTGAATTTCGGATTC\
ACCAT, TGATCAGTTCTTCGCT\
TCCGCCTCCTCCGCCCTCGTG\
CCACTCGATCTTCTGAGCCTCG\
AAGATGTCGTTCAGACCGCCCT\
GAAAATACAGGTTTTCTCCGCC\
TCCTCCGCCCTGTGCGGTGAC\
TGCGACC, AGCGAAGAACTGA\
TCAAAGAAAAC, GGTAGAATTA\
TCTAGTCAGTTCAGTTTATGAC\
CCAGTTTSigma-AldrichN/APrimers for HA-BirA in pLVX-IRES-Hyg: CGGTGAATTCCT\
CGAATGTACCCATACGATG\
TTCCAGATTACGCTGGCGG\
AGGAGGCGGAAAGGATAAC\
ACCGTGCCACTG, AGAGGG\
GCGGGATCTTATTATTTTTCT\
GCACTACGCAGGSigma-AldrichN/A**Recombinant DNA**pTC069 (pLVX-Puro-GCP2-mGFP-AviTag)This studycDNA from Origene (NCBI Reference Sequence: NM_001256617.1)pTC070 (pLVX-IRES-Hyg-HA-BirA)This studyBirA sequence taken from plasmid pJR284**Software and Algorithms**Fiji for image analysisNIH, USA<https://fiji.sc/>Matlab for image alignmentMathWorks<https://www.mathworks.com/products/matlab.html>RELION-3.0[@bib56], [@bib72]<https://www2.mrc-lmb.cam.ac.uk/relion/index.php?title=Main_Page>EMAN2 v2.07[@bib58]<https://blake.bcm.edu/emanwiki/EMAN2>Gctf v.1.18[@bib69]<https://doi.org/10.1016/j.jsb.2015.11.003>MotionCor2[@bib70]<https://msg.ucsf.edu/em/software/motioncor2.html>crYOLO (SPHIRE Package)[@bib65]<https://msg.ucsf.edu/em/software/motioncor2.html>cryoSPARC v2[@bib48]<https://www.nature.com/articles/nmeth.4169>PHENIX v1.13[@bib2], [@bib3], [@bib60]<http://www.phenix-online.org/>UCSF Chimera[@bib46]<https://www.cgl.ucsf.edu/chimera/>iTasser[@bib54]<https://www.nature.com/articles/nprot.2010.5>Coot v0.8.8[@bib15]<http://scripts.iucr.org/cgi-bin/paper?S0907444910007493>Namdinator[@bib30]<http://journals.iucr.org/m/issues/2019/04/00/eh5002/index.html>xiSEARCH[@bib42]<https://www.rappsilberlab.org/software/xisearch>xiFDR[@bib18]<https://www.rappsilberlab.org/software/xifdr>**Other**HiPrep 26/10 Desalting columnGE HealthcareCat\#: 17508701HiTrap Desalting columnGE HealthcareCat\#: 17140801HiTrap SP Sepharose FF columnGE HealthcareCat\#: 17505401Streptavidin mutein matrixSigma-AldrichCat\#: 3708152001Superose 6 10/300 GL columnGE HealthcareCat\#: 29091596Superdex Peptide 3.2/300 columnGE HealthcareN/ALacey grids (400 mesh) with a layer of ultra-thin carbonAgar ScientificCat\#: AGS187-450-centimetre EASY-Spray C18 LC columnThermo ScientificN/A

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Thomas Surrey (<thomas.surrey@crg.eu>).

### Materials Availability {#sec4.2.2}

Plasmids and the cell line generated in this study are available upon request.

### Data and Code Availability {#sec4.2.3}

The electron microscopy map has been deposited to the Electron Microscopy Data Bank under accession numbers EMD-10744. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD018106.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Escherichia coli bacterial strains DH5a and DH10MultiBac were grown in Luria Bertani (LB) medium in the appropriate antibiotics. HeLa-Kyoto cells (RRID:CVCL_1922) were cultured at 37°C (10% CO~2~) in Dulbecco\'s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 50 U mL^-1^ penicillin and 50 μg mL^-1^ streptomycin. Absence of mycoplasma contamination was verified regularly.

Method Details {#sec4.4}
--------------

### Lentivirus Expression Constructs and Molecular Biology {#sec4.4.1}

To generate a fluorescently-tagged and biotinylatable human γTuRC, the coding region for full-length human GCP2 (amino acids 1-902) was amplified by PCR using its cDNA as template (NM_001256617.1, Origene). The mTagBFP (blue fluorescent protein, Evrogen) coding sequence was also amplified by PCR. Both PCR-amplified sequences were cloned into a pLVX-Puro vector (Clonetech) using Gibson assembly (In-Fusion cloning, Takara), to form GCP2_G~5~A_TEV_G~5~A_mTagBFP_G~5~A_BAP, an expression construct for GCP2 which is C-terminally tagged with mTagBFP and biotin acceptor peptide (BAP: GLNDIFEAQKIEWHE), both separated from GCP2 by a TEV protease cleavage site. Glycine linkers (G~5~A) were placed between sequences. To facilitate the *in vivo* biotinylation of tagged γTuRC *E. coli* biotin ligase BirA was cloned into a pLVX-IRES-Hyg vector (Clonetech) using Gibson assembly to form HA\_ G~5~A_BirA; an expression construct of BirA with an HA-tag added to the BirA N-terminus, separated by a G~5~A-linker. Primers used for cloning are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}.

### Antibodies {#sec4.4.2}

Commercial and custom-made antibodies were used for the characterization of purified γTuRC by western blotting (see [Key Resources Table](#sec4.1){ref-type="sec"}). Custom-made antibodies were raised against His~6~-tagged proteins expressed and purified from *E. coli*. Specific antibodies were affinity purified by standard methods using MBP-tagged proteins expressed and purified from *E. coli* and coupled to CNBr-beads (GE Healthcare). The specificity of custom-made antibodies was confirmed by western blotting against human cell lysate after RNAi depletion of target proteins for 72 h using the RNAiMAX Transfection procedure (Thermo Fisher) and the RNA oligonucleotide sequences described previously ([@bib14]). For detection of biotinylated proteins by western blot, peroxidase coupled streptavidin (streptavidin-HRP, Thermo Fisher) was used.

### Cell Culture and Cell Line Development {#sec4.4.3}

To generate HeLa-Kyoto cells stably expressing biotinylated mTagBFP-tagged GCP2, cells were co-transduced with GCP2 and BirA lentivirus ([@bib1]) followed by hygromycin and puromycin selection. Resistant cells expressing mTagBFP were sorted by FACS (fluorescent assisted cell sorter) and cultured independently in 96 well plates. The isolated single-cell colonies were screened for HA-BirA expression by immunofluorescence staining (primary antibody: mouse anti-HA (F-7, Santa Cruz Biotechnology); secondary antibody: goat anti-mouse-FITC (Sigma)) and then using high throughput imaging (High throughput screening facility, Francis Crick Institute). The localisation of GCP2-mTagBFP-BAP was confirmed by live-cell fluorescence imaging using a spinning disc confocal microscope based on a NikonTI-E frame with a 100x 1.49 N.A. Nikon objective lens (Cairn Research, Faversham, UK). mTagBFP expressing colonies were further tested by western blotting to confirm the expression of GCP2-mTagBFP-BAP and HA-BirA.

When producing large cell cultures for purification, three days before harvesting cells (using trypsination), D-biotin (Sigma Aldrich) was added to a final concentration of 50 μM. Cell pellets were stored at -80°C until further use.

### Purification of Human γTuRC {#sec4.4.4}

Cells were resuspended in lysis buffer (50 mM HEPES, 150 mM KCl, 5 mM MgCl~2~, 1 mM EGTA, 1 mM DTT, 0.1 mM GTP, pH 7.4) containing protease inhibitors (complete EDTA-free protease inhibitor mix, Roche) and DNAse I (10 μg ml^-1^, Sigma-Aldrich). Resuspended cells were lysed using a polytron tissue dispenser (3x90 s at 6.6x10^3^ rpm) and lysate was clarified twice by centrifugation (17,000xg, 15 min, 4°C). Clarified lysate was filtered through three sets of filters with decreasing pore size: 1.2 μm (GE Healthcare), 0.8 μm (GE-Healthcare) and 0.45 μm (Millipore). The lysate was buffer exchanged into storage buffer (lysis buffer containing 0.02% (vol./vol.) Brij-35) over HiPrep 26/10 desalting columns to remove D-biotin from the lysate. Protein-containing fractions were pooled, supplemented with protease inhibitors and loaded onto a 1 mL HiTrap SP Sepharose FF column connected in tandem with 1 mL streptavidin mutein matrix beads (Sigma Aldrich) packed into a Tricorn 5/50 column (GE-Healthcare). The streptavidin mutein matrix column was washed with 30 mL storage buffer, 30 mL wash buffer (lysis buffer containing 200 mM KCl and 0.2% (vol./vol.) Brij-35) and 30 mL storage buffer. Proteins were eluted with storage buffer supplemented with 5 mM D-biotin. The buffer was then exchanged back into storage buffer using a HiTrap Desalting column. Protein-containing fractions were pooled and concentrated using Amicon centrifugal units (MWCO 30^,^000, Millipore), centrifuged (17,000xg, 10 min, 4°C) and separated by size exclusion chromatography using a Superose 6 10/300 GL column. γTuRC peak fractions were pooled, concentrated, ultracentrifuged (278,088.3xg, 10 min, 4°C), snap frozen and stored in liquid nitrogen. From 120 g of cell pellet typically ∼85 μg of tagged γTuRC were purified.

### Purification of Human chTOG-mGFP, mGFP-TPX2 and mGFP-EB3 {#sec4.4.5}

GFP-tagged microtubule binders were purified as described ([@bib50], [@bib52]). In brief, StrepTagII-chTOG-mGFP was expressed in Sf21 cells and affinity purified using a StrepTrap HP column. After removal of the N-terminal StrepTagII by tobacco etch virus (TEV) protease, chTOG-mGFP was further purified by size exclusion chromatography. StrepTagII-mGFP-TPX2 was expressed in Sf21 cells and affinity purified using a StrepTrap HP column. After removal of the N-terminal StrepTagII by TEV protease, mGFP-TPX2 was further purified by anion exchange chromatography and size exclusion chromatography. His~6~-tagged mGFP-EB3 was expressed in E. coli (BL21 pRIL) and affinity purified using a HiTrap Chelating column. After removal of the N-terminal His~6~-tag by TEV protease, mGFP-EB3 was further purified by size exclusion chromatography.

### Tubulin Purification and Labelling {#sec4.4.6}

Porcine brain tubulin was purified and covalently labelled with NHS-biotin (Thermo Fisher) or NHS-CF640R (Sigma-Aldrich) using standard procedures ([@bib12], [@bib29]). CF640R-tubulin was labelled at a ratio of 0.4 fluorophores per tubulin dimer.

### LC-MS/MS Analysis of Fluorescently Tagged γTuRC {#sec4.4.7}

Purified γTuRC was separated by SDS-PAGE and stained using InstantBlue (Expedeon). Protein bands were excised from the gel and analysed by the Francis Crick Institute Proteomics facility. Briefly, Tryptic peptides were analysed using a Q Exactive orbitrap mass spectrometer coupled to an Ultimate 3000 HPLC equipped with an EasySpray nano-source (Thermo Fisher Scientific). A one-hour method of MS1 orbitrap (60k resolution) followed by top 10 HCD MS2 (35k resolution) produced raw data files. Raw files were analysed in MaxQuant (v1.6.0.13) against the SwissProt Homo sapiens protein database (downloaded June 2019) using the iBAQ algorithm. The canonical GCP2 sequence was replaced with the construct sequence (GCP2-5xGly-TEV-5xGly-mBFP-5xGly-AviTag). Variable modifications of methionine oxidation and protein N-terminal acetylation along with a fixed modification of cysteine carbamidomethylation were selected. The proteingroups.txt file was imported in Perseus (v1.4.0.2) for data analysis. Potential contaminants, reverse sequences and proteins identified by site were removed. iBAQ intensities were log~2~ transformed.

### γTuRC-Mediated Microtubule Nucleation Assay {#sec4.4.8}

To study microtubule nucleation by γTuRC, we modified a previous TIRF microscopy-based surface nucleation assay without γTuRC ([@bib50]). Flow chambers were assembled from one biotin-polyethylene glycol (PEG)-functionalized coverglass and one poly(L-lysine)-PEG-passivated counter glass.

Biotin-PEG-functionalized glass was prepared essentially as described ([@bib8]), with some modifications. In brief, 22 x 22 mm coverglasses (Menzel Gläser; \#1.5) were sonicated in 3 M NaOH for 30 min, rinsed with Milli-Q water, sonicated in Piranha solution (95-97% H~2~SO~4~/30% H~2~O~2~ (3/2 (vol./vol.))) for 45 min in a fume hood, washed with Milli-Q water, sonicated for 5 min in Milli-Q water, and washed again in Milli-Q water. After spin-drying, sandwiches consisting of two coverglasses with (3-Glycidyloxypropyl)trimethoxy-silane (GOPTS) (Sigma Aldrich; 440167) in between them were kept at 75°C for 30 min, left to cool for 15 min before glass sandwiches were separated. After being kept in acetone for 2 x 15 min, coverglasses were spin-dried and assembled into another sandwich with ∼50 mg of PEG mix (biotin-CONH-PEG-NH~2~ (Rapp Polymere; 133000-25-20)/HO-PEG-NH~2~ (Rapp Polymere; 10300-20) (1/10 (w/w))), ensuring that the pre-functionalized sides of the glasses are on the inside of the sandwich. Sandwiches were kept at 75°C overnight after removing any air from the inside of the sandwich. After separation, coverglasses were sonicated for 30 min in Milli-Q water, washed with Milli-Q water, spin-dried and stored at 4°C for a maximum of 2 months.

Poly(L-lysine)-PEG-passivated counter glass was prepared by spreading 10 μL of 2 mg/mL Poly(L-lysine)-PEG (SuSoS) between two strips of double-sided tape (placed ∼5 mm apart parallel to one another) on a microscopy glass (76x26 mm, VWR, 631-1550P) and left to dry for at least 20 min. The glass was washed with water and dried with N~2~.

For a microscopy assay, a flow chamber consisting of one biotin-PEG-coverglass and a poly(L-lysine)-PEG counter glass was incubated for 10 min with 5% Pluronic F-127 (Sigma Aldrich) in MilliQ water, washed with assay buffer (AB: 80 mM PIPES, 60 mM KCl, 1 mM EGTA, 1 mM MgCl~2~, 1 mM GTP, 5 mM 2-mercaptoethanol, 0.15% (w/vol.) methylcellulose (4,000 cP, Sigma-Aldrich) 1% (w/vol.) glucose, 0.02% (vol./vol.) Brij-35)) supplemented with 50 μg mL^-1^ κ-casein (Sigma-Aldrich), followed by a 3-min incubation with the same buffer additionally containing 50 μg mL^-1^ of NeutrAvidin (Life Technologies). The chamber was subsequently washed with γTuRC storage buffer and incubated for 5 min with prediluted γTuRC in γTuRC storage buffer to the concentration indicated for each experiment. Unbound γTuRC was removed by washing the flow cell with AB. Then the final assay mix was passed through, the chamber was sealed with vacuum grease (Beckman) and placed onto the microscope.

Final assay mix: AB supplemented with oxygen scavengers (160 μg mL^-1^ catalase (Sigma-Aldrich), 680 μg mL^-1^ glucose oxidase (Serva)) diluted in BRB80 (80mM PIPES, 1mM EGTA, 1mM MgCl~2~), 1 mg ml^-1^ bovine serum albumin (Sigma-Aldrich) in BRB80, varying concentrations of tubulin (containing 4.8% CF640R-labelled tubulin). For experiments with microtubule binders 2.9% (vol./vol.) of either chTOG-mGFP, mGFP-TPX2 or mGFP-EB3 was added at different concentrations. chTOG-mGFP and mGFP-TPX2 concentrations were altered by predilution in their storage buffers ([@bib201], [@bib50]). mGFP-EB3 was diluted in BRB80. The final assay mix containing chTOG-GFP was ultracentrifuged (278,088.03xg, 10 min, 4°C) before flowing the mix into the chamber. To keep the buffer composition of the final assay mix unchanged within a set of experiments and to allow for direct comparisons between experiments, the overall BRB80 and storage buffer content was kept constant within one set of experiments.

### Microtubule Dynamics Assays Using \'Seeds\' {#sec4.4.9}

To image the properties of microtubules having both dynamic plus and minus ends, microtubules were grown from pre-polymerized and immobilized GMPCPP-stabilized microtubules (\'seeds\'). Dynamics assays were performed as nucleation assays, but instead of γTuRC biotinylated and fluorescently labelled microtubule seeds were bound to the glass surface. Seeds were prepared as described previously ([@bib8]), here containing 39% CF640R-labelled tubulin.

In brief, 6.7 μM tubulin, 5 μM biotinylated tubulin and 7.1 μM CF640R-labelled tubulin and 0.5 μM GMPCPP (Jena bioscience, NU-405S) in BRB80 was incubated for 1 h at 37°C, diluted 8.33-fold with prewarmed BRB80 and centrifuged at 17,000 g at room temperature for 10 min. The pellet was resuspended in prewarmed BRB80 and centrifuged at 17,000 g for 2 min, followed again by resuspension of the pellet in prewarmed BRB80. Microtubule seeds were kept at room temperature and used on the same day.

### TIRF Microscopy {#sec4.4.10}

All experiments were performed using a total internal reflection fluorescence (TIRF) microscope (Cairn Research, Faversham, UK) ([@bib27]). Experiments were imaged 2 min after placing the chamber on the microscope. The temperature was kept at 33±1°C for all experiments. Two- and three-colour time-lapse imaging for γTuRC nucleation assays and dynamics assays were performed at 1 frame/5 s with a 300-ms exposure time for tubulin (640 nm) and GFP (480 nm) channels and 1000-ms for γTuRC-mBFP (408 nm) using a 60x 1.49 NA Nikon objective lens. For single molecule γTuRC assays shown in [Figure 2](#fig2){ref-type="fig"}F, images were acquired at 1 frame/1.8 s with a 500-ms exposure time using a 100x 1.49 N.A. Nikon objective lens. CF640R-tubulin (640 nm excitation) and mGFP-tagged proteins (488 nm excitation) were imaged simultaneously. γTuRC-mTagBFP-BAP (405 nm excitation) was imaged every 10 frames for single molecule γTuRC assays and once at the beginning and at the end of the movie for γTuRC nucleation assays.

### TIRF Microscopy Image Processing {#sec4.4.11}

The Fiji package of ImageJ was used to generate kymographs (space-time plots) and to merge image sequences from different channels. For multi-colour imaging, image alignment was performed using a Matlab script ([@bib41]). Background was subtracted using the background subtraction tool of Fiji ('rolling ball' method). For movies from single molecule γTuRC assays shown in [Figure 2](#fig2){ref-type="fig"}F γTuRC-mTagBFP-AviTag images were merged using the 'grouped Z project' function in Fiji. To subtract camera noise an empty flow chamber was imaged using the same imaging conditions. The background image was generated as described above and subtracted from the γTuRC-mTagBFP-AviTag image, which was then used to merge with images of CF640R-tubulin.

### Microtubule Growth Speeds {#sec4.4.12}

Growth speeds were measured directly from kymographs using the 'Resclice function' in Fiji. Lines were drawn manually along growing plus- and minus-ends. Growth speeds were calculated from the slope of the line. The total number of microtubules used for the measurement of growth speeds for each experimental condition is stated in the corresponding figure legend and data was pooled from at least three independent experiments if not stated otherwise. For conditions with high nucleation rates, at least 50 microtubules per experimental repeat were analysed. For condition with low nucleation rates, all microtubules with a minimum lifetime of ∼2 min were used for analysis.

### Microtubule Nucleation Rate Analysis {#sec4.4.13}

For each nucleation assay, microtubules were counted manually at 10 different time points either until the end of the movie or until individual microtubule nucleation events could no longer be identified due to overcrowding. The total number of nucleated microtubules in a field of view at a given time point was obtained by counting the newly nucleated microtubules and adding it to the number obtained at the previous analysed time point. Microtubule numbers were tracked using the 'Point tool' together with the 'ROI manager tool' in Fiji. For the quantification of γTuRC-mediated microtubule nucleation rates, only microtubules were counted that started nucleating from the surface and that stayed surface-attached. Microtubule nucleation rates represent the slope of the linear regression for each condition and are given in number per nucleated microtubules per field of view and per time.

### Negative Stain Grid Preparation and Data Collection {#sec4.4.14}

A 4-μl droplet of human γTuRC (purified as described above) diluted in γTuRC storage buffer was applied to a freshly glow-discharged carbon-coated grid (C300Cu100, EM Resolution) and incubated for 2 min. The grid was stained with consecutive applications onto three 50-μl droplets of 2% uranyl acetate solution for 30 s each. The grid was then blotted dry and stored until imaged on a 120 keV G2 Spirit transmission electron microscope (FEI) equipped with a 2k×2k Ultrascan-1000 camera (Gatan). The Micrographs were collected using a nominal magnification of 30,000x, resulting in a pixel size of 3.45 Å at the specimen level.

### Cryo Grid Preparation and Data Collection {#sec4.4.15}

Freeze-thawed human γTuRC (purified as described above) was briefly spun to remove aggregates. Lacey grids (400 mesh) with a layer of ultra-thin carbon (Agar Scientific) were glow-discharged at 45 mA for 1 min using a K100X Glow Discharge Unit (EMS). A 4 μl-droplet was then applied directly onto the carbon-side of the grid loaded into the humidity chamber of a Vitrobot Mark IV (Thermo Fisher) set to room temperature and 90% humidity. After an incubation time of 60 seconds, the grid was blotted for 3s and plunged into liquid ethane. The ice quality was assessed on a 200 kV Talos Arctica (Thermo Fisher) and a small dataset was collected to evaluate the sample quality.

The highest-quality grid was imaged using a 300kV Titan Krios electron microscope (Thermo Fisher) using a GIF Quantum energy filter (Gatan) and a K2 Summit direct detector (Gatan), operated in counting mode. A total of 2,4000 movies were collected over two sessions at a pixel size of 1.08 Å/px with a total dose of ∼50 e−/A2 and a defocus range of -1.0 - -3.5 μm.

### Negative Stain Electron Microscopy Image Processing {#sec4.4.16}

The particles were picked using e2boxer.py of the EMAN2 v2.07 software package ([@bib58]), using the semi-automated (swarm) option. Box files were then imported in the RELION-3.0 ([@bib72]), which was used for all downstream image processing steps that were performed. Contrast transfer function parameters were determined using Gctf v.1.18 ([@bib69]), and extracted particles were subjected to two-dimensional classification.

### Cryo-EM Image Processing {#sec4.4.17}

To correct for beam-induced movements all movie frames were aligned using dose-weighted averaging in MotionCor2([@bib70]). CTF parameters were estimated using non-dose-weighted micrographs generated by Gctf v.1.18 ([@bib69]). Automated particle-picking was performed using crYOLO of the SPHIRE software package ([@bib65]). Box files were imported in RELION-3 ([@bib72]) and a total of ∼ 1.1 million particles were initially binned by a factor of four and extracted from dose-weighted micrographs with a box size of 128 pixels. After several rounds of two-dimensional classification, a total of 522,496 high-resolution particles were selected, which evidently contained high-resolution information. Unbinned particles were re-extracted, using a 512-pixel box size. These particles were used to generate three reference free *ab initio* models using cryoSPARC v2 ([@bib48]). The best model, which resulted from 229,744 particles, was imported in RELION-3, filtered to 60 Å and used as a starting reference for 3D classification of the 522,496 high-resolution particles. The combination of all particles yielded in the highest resolution class, which was subsequently subjected to one initial 3D refinement, followed by three rounds of CTF refinement and one Bayesian particle polishing step. Polished particles were subjected to one final round of CTF refinement, 3D refinement and post processing, yielding in a final 3D structure with an overall resolution of 4 Å. Further cryoEM density modification implemented in Phenix ([@bib60]) increased the resolution to 3.7 Å (used for display in figures showing amino acid chains). Although BFP was present in the complex, fused to the C-terminus of GCP2, density for this tag was not visible in the cryo-EM structure, due to both flexibility and the mixture of tagged and untagged GCP2 found in the complex.

### Generation of an Atomic Model {#sec4.4.18}

The crystal structure of human GCP4 (PDB entry [3RIP](pdb:3RIP){#intref0140}) ([@bib24]) was separated in three distinct domains and used for docking into the cryo-EM map, using the Fit in map option in UCSF Chimera ([@bib46]). Highest correlation GCP subunits were assigned to GCP4, while GCP3 was recognised because of a characteristic helical extension in the C-terminal γ-tubulin interacting domain, first modelled using iTasser ([@bib54]), adjusted manually in Coot ([@bib15]) and refined using Phenix ([@bib3]) and Namdinator ([@bib30]). Other GCP assignments were based on CLMS results (detailed below).

### Crosslinking and Mass Spectrometry {#sec4.4.19}

The purified γTuRC complex at a concentration of 0.2 mg/ml in gel filtration buffer (50 mM HEPES pH 7.4, 150 mM KCl, 1 mM MgCl~2~, 1 mM EGTA, 1 mM DTT, 0.1 mM GTP and 0.02 % Brij-35) was crosslinked with 2.4 mM disulfosuccinimidyl suberate (BS3) in a thermomixer for 1 h at 24°C and 850 rpm. The reaction was quenched with 92 mM NH~4~HCO~3~ in a thermomixer for 30 min at 24°C and 850 rpm. The crosslinked sample was cold-acetone precipitated. The dried protein pellet was resolubilized in 40 μL digestion buffer (8M urea in 100 mM ammonium bicarbonate (ABC) with 1 mM Dithiothreitol (DTT)) to an estimated protein concentration of 1 mg/mL. Dissolved protein sample was reduced by addition of 0.2 uL 1M DTT, the reduction reaction was incubated at room temperature for 30 minutes. The free -SH groups in the sample were then alkylated by adding 1.2 uL 500 mM Iodoacetamide (IAA) and incubating at room temperature for 20 minutes. After alkylation, 0.2 uL 1M DTT was added to quench excess of IAA. Subsequently, protein sample was digested with LysC (with 1:50 (m/m) protein to protease ratio) at room temperature for four hours. The sample was then diluted with 100 mM ABC to reach urea concentration of 1.5 M. Trypsin was added with 1:50 (m/m) protein to protease ratio to further digest proteins for over night (∼15 hours) at room temperature. Resulting peptides were de-salted using C18 StageTips (PMID:[17703201](pmid:17703201){#intref0145}).

20% of total peptides were directly analysed by liquid chromatography--tandem mass spectrometry (LC-MS/MS) in duplicate. The remaining 80% peptides were fractionated using size exclusion chromatography in order to enrich for crosslinked peptides (PMID:[24356771](pmid:24356771){#intref0150}). Peptides were separated using a Superdex Peptide 3.2/300 column (GE Healthcare) at a flow rate of 10 μl/min. The mobile phase consisted of 30% (v/v) acetonitrile and 0.1% trifluoroacetic acid. The earliest six peptide-containing fractions (50 μl each) were collected. Solvent was removed using a vacuum concentrator. The fractions were then analysed by LC-MS/MS.

LC-MS/MS analysis was performed using an Orbitrap Fusion Lumos Tribrid mass spectrometer (Thermo Fisher Scientific), connected to an Ultimate 3000 RSLCnano system (Dionex, Thermo Fisher Scientific). Each SEC fraction was resuspended in 1.6% v/v acetonitrile 0.1% v/v formic acid and analysed with two LC-MS/MS acquisitions. Peptides were injected onto a 50-centimetre EASY-Spray C18 LC column (Thermo Scientific) that is operated at 50°C column temperature. Mobile phase A consists of water, 0.1% v/v formic acid and mobile phase B consists of 80% v/v acetonitrile and 0.1% v/v formic acid. Peptides were loaded and separated at a flowrate of 0.3 μL/min. Eluted peptides were ionized by an EASY-Spray source (Thermo Scientific) and introduced directly into the mass spectrometer.

For non-fractionated samples, peptides were separated using a linear gradient going from 2% mobile phase B to 40% mobile phase B over 110 minutes, followed by a linear increase from 40% to 95% mobile phase B in eleven minutes. The MS data is acquired in the data-dependent mode with three-second acquisition cycle. The full scan mass spectrum was recorded in the Orbitrap with a resolution of 120,000. The ions with a charge state from 3+ to 7+ were isolated and fragmented using higher-energy collisional dissociation (HCD) with 30% collision energy. The fragmentation spectra were then recorded in the Orbitrap with a resolution of 50000. Dynamic exclusion was enabled with single repeat count and 60-second exclusion duration.

The collected SEC fractions were each analysed with duplicated acquisitions. Peptides were separated by applying a gradient ranging from 2% to 45% B over 90 min. Gradient was optimized for each corresponding SEC fraction. Following the separating gradient, the content of B was ramped to 55% and 95% within 2.5 minutes each. The MS data is acquired in the data-dependent mode with the top-speed option. For each three-second acquisition cycle, the full scan mass spectrum was recorded in the Orbitrap with a resolution of 120,000. The ions with a charge state from 3+ to 7+ were isolated and fragmented using Higher-energy collisional dissociation (HCD). For each isolated precursor, one of three collision energy settings (26%, 28% or 30%) was selected for fragmentation using data dependent decision tree based on the m/z and charge of the precursor. The fragmentation spectra were then recorded in the Orbitrap with a resolution of 50000. Dynamic exclusion was enabled with single repeat count and 60-second exclusion duration.

The MS2 peak lists were generated from the raw mass spectrometric data files using the MSConvert module in ProteoWizard (version 3.0.11729). The default parameters were applied, except that Top MS/MS Peaks per 100 Da was set to 20 and the de-noising function was enabled. Precursor and fragment m/z values were recalibrated. Identification of crosslinked peptides was carried out using xiSEARCH software (<https://www.rappsilberlab.org/software/xisearch>) (PMID:[31556486](pmid:31556486){#intref0160}). Peak lists from all LC-MS/MS acquisitions were searched against the sequence and the reversed sequence of γTuRC subunits. The following parameters were applied for the search: MS accuracy = 5 ppm; MS2 accuracy = 10 ppm; enzyme = trypsin (with full tryptic specificity); allowed number of missed cleavages = two; missing monoisotopic peak=2 5; cross-linker = BS3 the reaction specificity for BS3 was assumed to be for lysine, serine, threonine, tyrosine and protein N termini); fixed modifications = carbamidomethylation on cysteine; variable modifications = oxidation on methionine, modifications by BS3 that are hydrolyzed or amidated on the end. Identified crosslinked peptide candidates were filtered using XiFDR (PMID: [28267312](pmid:28267312){#intref0165}). A false discovery rate (FDR) of 2% on residue-pair-level was applied with "boost between" option selected. A list of identified crosslinked residue pairs is reported in [Data S2](#mmc11){ref-type="supplementary-material"}. Structural interpretation of inter-protein crosslinks was focused on protein pairs that were crosslinked with three or more residue pairs. The pseudo-atomic model of γTuRC complex was compared against the crosslinking data. The distances between the Cα atoms of crosslinked residue pairs in the model were measured and compared against a theoretical crosslinking limit of 30 Å for crosslinker BS3 (calculated based the spacer of the crosslinker and the length of the side chains of crosslinked residues).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Image analysis was performed with the Fiji package of ImageJ and Matlab. Plots were generated in GraphPad Prism. Data were pooled from at least three independently performed experiments if not stated otherwise. All error bars represent the standard error of mean (s.e.m.) or standard deviation (s.d.) as indicated in each Figure. Linear regression and curve fitting were performed using GraphPad Prism. Details of the analysis are given in the [STAR Methods](#sec4){ref-type="sec"} DETAIL section.
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